SonoSite expands GE patent lawsuit:
This article was originally published in Clinica
Hand-carried ultrasound developer SonoSite has amended details of its ultrasound patent infringement countersuit against GE. The revised lawsuit now asserts that GE's Vivid and Logiq ultrasound products, certain transducers and the Vivid 7 cart-based system infringe two other patents '566 and '839 related to ultrasound technology with ECG modules and software in a detachable scanhead, in addition to the previous patents mentioned in the original complaint. SonoSite (Bothell, Washington) first filed its counterclaim in July this year in reaction to GE's lawsuit, which alleged that the former's MicroMaxx and Titan imaging systems contravened five patents related to technology that displays blood flow via ultrasound (see Clinica No 1264, p 15).
You may also be interested in...
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
As part of its efforts to preserve patient access to medicines amid the COVID-19 pandemic, Russia is planning to cap drug prices if increases of more than 30% are detected. It will also allow online sales of non-prescription drugs and may also tighten the rules on fake and substandard products.
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.